We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges

    Central nervous system (CNS) infections carry a substantial burden of morbidity and mortality worldwide, and accurate and timely diagnosis is...

    LingHui David Su, Charles Y. Chiu, ... Anne Piantadosi in Molecular Diagnosis & Therapy
    Article 11 July 2024
  2. Genetic constraint at single amino acid resolution in protein domains improves missense variant prioritisation and gene discovery

    Background

    One of the major hurdles in clinical genetics is interpreting the clinical consequences associated with germline missense variants in...

    **aolei Zhang, Pantazis I. Theotokis, ... James S. Ware in Genome Medicine
    Article Open access 11 July 2024
  3. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments

    As one of the significant challenges to human health, cancer has long been a focal point in medical treatment. With ongoing advancements in the field...

    Zhuo Yan, Zhengbo Zhang, ... Zhangquan Wang in Cancer Cell International
    Article Open access 11 July 2024
  4. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

    Background

    Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in...

    Prachi Bajpai, Sumit Agarwal, ... Upender Manne in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  5. Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously

    Background

    Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the...

    Wen Luo, Hai Hoang, ... Mitchell S. Cairo in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  6. The black box of the relationship between breast cancer patients and accompanying patients: the accompanied patients’ point of view

    Background

    The PAROLE-Onco program was introduced in the province of Quebec, Canada in 2019. It integrates accompanying patients (APs), i.e., people...

    Marie-Pascale Pomey, Monica Iliescu Nelea, ... Michèle de Guise in BMC Cancer
    Article Open access 10 July 2024
  7. Associations between modifiable risk factors and hepatocellular carcinoma: a trans-ancestry Mendelian randomization study

    Background

    Potentially modifiable risk factors for hepatocellular carcinoma (HCC) have been investigated in observational epidemiology studies in East...

    **aoxia Wei, Chenglei Yang, ... Yingchun Liu in BMC Cancer
    Article Open access 10 July 2024
  8. Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer

    Pancreatic cancer, characterized by its poor prognosis, exhibits a marked resistance to conventional chemotherapy and immunotherapy, underscoring the...

    Yiwei Wang, Ting Xu, ... **nyu Huang in Cancer Cell International
    Article Open access 10 July 2024
  9. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review

    Background

    Hospitalisation  resulting from complications of systemic therapy and radiotherapy places a substantial burden on the patient, society, and...

    Rashidul Alam Mahumud, Md. Shahjalal, ... Olivia Wawryk in BMC Cancer
    Article Open access 10 July 2024
  10. Influence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma

    Immune response is known to play an important role in local tumor control especially in renal cell carcinoma (RCC), which is considered highly...

    Johanna Waidhauser, Anna-Katharina Gantner, ... Thomas Kröncke in BMC Cancer
    Article Open access 10 July 2024
  11. Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

    Infection is the leading cause of death in multiple myeloma (MM). However, the cellular composition associated with immune dysfunction is not...

    Esperanza Martín-Sánchez, Luis-Esteban Tamariz-Amador, ... Jesus F. San Miguel in Blood Cancer Journal
    Article Open access 10 July 2024
  12. miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer

    Background

    Colorectal cancer (CRC) is ranked as the third most commonly diagnosed cancer and the third cause of cancer related deaths. CRC is greatly...

    Marwa Matboli, Nourhan Hossam, ... Sanaa Eissa in BMC Cancer
    Article Open access 10 July 2024
  13. Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis

    Introduction

    The incidence of colorectal cancer (CRC) has been increasing in Sub-Saharan countries, including Ethiopia. However, the real mortality...

    Zewdu Bishaw Aynalem, Abebaw Bires Adal, ... Tilahun Degu Tsega in BMC Cancer
    Article Open access 10 July 2024
  14. Unmutated RRAS2 emerges as a key oncogene in post-partum-associated triple negative breast cancer

    Background

    Breast cancer (BC) is the most common cancer in women, with triple negative BC (TNBC) accounting for 20% of cases. While early detection...

    Claudia Cifuentes, Clara L. Oeste, ... Balbino Alarcón in Molecular Cancer
    Article Open access 10 July 2024
  15. The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies

    Pyroptosis is a cell death process characterized by cell swelling until membrane rupture and release of intracellular contents. As an effective tumor...

    Mengyuan Hu, Fengying Deng, ... Fei Yan in Journal of Experimental & Clinical Cancer Research
    Article Open access 10 July 2024
  16. Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality

    Background

    To assess cancer-specific mortality (CSM) and other-cause mortality (OCM) rates in patients with rare histological prostate cancer subtypes.

    ...
    Carolin Siech, Mario de Angelis, ... Pierre I. Karakiewicz in Prostate Cancer and Prostatic Diseases
    Article Open access 10 July 2024
  17. Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism

    Background/objectives

    Extramammary Paget disease (EMPD) is a rare, cutaneous intraepithelial adenocarcinoma typically treated with wide local...

    Che-Yuan Hsu, Teruki Yanagi, ... Hideyuki Ujiie in British Journal of Cancer
    Article 10 July 2024
  18. PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial

    Background

    Approximately 40% of treated head and neck cancer (HNC) patients develop recurrence. The risk of recurrence declines with time from...

    Paul Nankivell, Piers Gaunt, ... Hisham Mehanna in BMC Cancer
    Article Open access 10 July 2024
  19. Identification of Immunodominant Epitopes of Dengue Virus 2 Envelope and NS1 Proteins: Evaluating the Diagnostic Potential of a Synthetic Peptide

    Background and Objective

    Dengue is a major infectious disease with potential for outbreaks and epidemics. A specific and sensitive diagnosis is a...

    Sushmita Singha, Neena Nath, ... Shashi Baruah in Molecular Diagnosis & Therapy
    Article 09 July 2024
Did you find what you were looking for? Share feedback.